Beatrice Hahn

Last updated
Beatrice Hahn
Born(1955-02-13)February 13, 1955
Munich, Germany
Alma mater Technical University Munich
Known for human immunodeficiency virus
SpouseGeorge Shaw
Scientific career
Institutions National Cancer Institute, University of Alabama at Birmingham, University of Pennsylvania

Beatrice H. Hahn (born February 13, 1955) is an American virologist and biomedical researcher best known for work which established that HIV, the virus causing AIDS, began as a virus passed from apes to humans. [1] [2] [3] She is a professor of Medicine and Microbiology in the Perelman School of Medicine at the University of Pennsylvania. [4] [5] In November 2002, Discover magazine listed Hahn as one of the 50 most important women scientists. [6]

Contents

Hahn discovered that the human immunodeficiency virus (HIV) originated in other primates and spilled over to humans. [4] Hahn and her research group established that wild-living chimpanzees in southern Cameroon were a natural reservoir of the closely related simian immunodeficiency viruses (SIVs). The team developed non-invasive techniques for gathering genetic data. By making comparisons between the genes of HIV-1 and SIVs, they found that SIVs had originated in apes, and had passed to humans through multiple connections. [3] [1] The simian versions of the virus (known as SIVcpz in chimpanzees, and SIVgor in gorillas) became the infection named HIV in humans. [7]

Hahn later determined that the malaria parasite also traversed from other primates to humans, in a single event. [4]

Early life and education

Beatrice Hahn was born in Munich, Germany on February 13, 1955. [1] [2] As a child, she was interested in medicine by her father's work as a primary care physician. [8] He was one of the first doctors in Bavaria to use an X-ray machine, and allowed Beatrice to use some of his medical equipment as she grew up. Hahn was fascinated by studying urine slides under the microscope, and taking blood samples. Her ambition to enter medicine dates from this period. [2]

Hahn left home to attend medical school at Technical University Munich, where she earned her M.D. degree in 1981. She worked as an intern at Ludwig Maximilian University of Munich from 1981 to 1982. [2] She attained her Doctorate in Medicine from Technical University Munich in 1982. [2]

Her doctoral thesis was again influenced by her upbringing and early childhood. [2] It was at this period that she began to specialise in zoonoses or infections which can be transmitted between species, and their implications for public health. [2] Hahn had herded and milked cows as a child in her native Bavaria, where cattle were important to the rural economy. She wondered if human populations might be affected by exposure to bovine viruses. Her thesis specifically focused on the bovine leukemia virus, a very serious disease in cattle, and its close relationship with the human tumor virus HTLV-1. [2]

Career

After graduating, Hahn began her career with a fellowship from the German Science Foundation in Robert Gallo's National Cancer Institute in Bethesda, Maryland. She decided to leave Germany because she believed she would have better opportunities for research and for funding in the United States. [2] In 1985, she joined the faculty of the University of Alabama at Birmingham (UAB) and established her own laboratory. [2] [7] She was a co-director of the Center for AIDS Research at UAB from 2003 to 2011. In 2011, Hahn joined the faculty of the Perelman School of Medicine at the University of Pennsylvania along with her husband and research partner George Shaw. [4] [5] Hahn and Shaw also work with CHAVI, a multi-institutional consortium. [1] Hahn is the lead researcher of CHAVI's Viral Biology Team. [9]

In addition to her work in universities and as a researcher, Hahn is also a member of the American Academy of Arts and Sciences, the American Academy of Microbiology, the National Academy of Medicine, and the National Academy of Sciences. She is also a member of the advisory board of the Bill and Melinda Gates Foundation's HIV/AIDS Program and has served on numerous NIH Counsel groups. [10]

Research

Hahn met Robert Gallo when she was a student at the Technical University of Munich. He was a virologist and a researcher at the National Cancer Institute in Bethesda, Maryland. Most of his research was focused on leukemia, the disease that had taken his sister's life at an early age. One of the main areas of interest for Gallo was tumor-causing retroviruses. [2] This sparked the interest of Hahn because Bovine leukemia virus is an example of such a retrovirus. [2] Hahn's wish to work in Gallo's lab was made possible when she received a fellowship from the German Science Foundation. [2]

Hahn left her home in Germany and started research at the National Cancer Institute on May 1, 1982. [2] There, she began her research into the origins of HIV/AIDS. AIDS had just become prevalent in the United States a year before she arrived. All of the patients with the reported disease were gay males and displayed symptoms of a skin cancer and unique form of pneumonia. [2] Gallo's laboratory had been studying this new disease outbreak and Hahn joined the investigation. [2]

In 1983, George Shaw joined Gallo's laboratory and he and Hahn began to collaborate on their research. After a fellow researcher, Mikulas Popovic, successfully cultured and isolated the virus, Hahn and Shaw cloned the virus's genome, becoming the first scientists to do so. [2]

They were able to determine that the isolated retrovirus was the cause of AIDS. They went on to discover that HIV originated from chimpanzees, gorillas, and sooty mangabey strains of simian immunodeficiency virus (SIV). Their team used non-invasive research techniques in order to study endangered species of primates in the wild. Contrary to the prevailing scientific opinion, Hahn found that SIV does cause disease in its hosts and that chimpanzees represent a reservoir of HIV. She also discovered that SIV could be transmitted sexually and through breast milk among chimpanzees. She has also cloned HIV-2 and catalogued genetic variants of HIV-1 and their drug resistance. [1] [2] [11]

Hahn and Shaw had many papers published (including a cover article for Nature) and in 1985 they were both recruited by the University of Alabama at Birmingham's Comprehensive Cancer Center to lead and conduct human retrovirus research. [2] Both excelled in their work and Hahn went on to become a distinguished professor in the Departments of Microbiology and medicine as well as work as co-director at the Center for AIDS research at UAB. Hahn and her long-time research partner George Shaw married in 1988. [2]

After working at UAB, Hahn and Shaw moved to the Center for AIDS Research at the University of Pennsylvania in 2011. [5] There she has used non-invasive fecal sampling to investigate SIV and HIV in primate populations. Her research has also included the origins of the human malaria parasite, Plasmodium falciparum; determining that P. falciparum was transmitted to humans from gorillas in a single event in West Africa. [2] [11]

Details of research

Hahn conducted her research from an evolutionary perspective when studying disease mechanisms and HIV/SIV gene function. Simian immunodeficiency viruses (SIVs) are a type of retroviruses that are capable of infecting a myriad of non-human primate species located in Africa. [12]

Hanh made the startling discovery that certain SIVs had traversed between humans and certain nonhuman primate species a multitude of times to result in types 1 and 2 human immunodeficiency virus (HIV). The two viruses she identified were SIVcpz from chimpanzees (Pan troglodytes) and SIVsmm from sooty mangabeys (Cercocebus atys). [12] The realization that the transfer of SIVs had generated HIV led Hahn to conclude that presence of Acquired Immunodeficiency Syndrome (AIDS) was due to the cross-species infections of humans by lentiviruses of primate origin. [12]

A careful analysis of the high degree of relatedness between chimpanzees and humans was a major focus in Hanh’s laboratory. Knowing that chimpanzees and humans share more than 98% sequence identity across their genomes, Hanh sought to uncover what exactly varies in the interactions between virus and host that cause differences in viral pathogenicity. [12] Hahn made advances in the understanding the origin of HIV-1, SIVcpz, and natural SIVcpz reservoirs. [3]

Study on Origin of HIV-1

The theorization that chimpanzees may be source of HIV-1 began when a chimpanzee was found to have a lentivirus (SIVcpzGAB1) that was closely related to HIV-1. [12] The genome of SIVcpzGAB1 had an accessory gene that was so far unique to HIV-1 as well as many of the same reading frames. However, experiments carried out on more chimpanzees continuously resulted in apparently contradictory results as to whether chimpanzees were the original source of the SIVcpz. [12]

One experiment performed on fifty chimpanzees resulted in only two possessing HIV-1 cross-reactive antibodies, which showed a much lower SIVcpz infection rate in contrast to other naturally occurring SIV infections. This finding indicated that there was a third unknown source that both humans and chimpanzees could have acquired the virus from. [12]

Another study reported that a chimpanzee named Noah had a virus called SIVcpzANT that clustered with SIVcpzGAB1 (and HIV-1 strains) in phylogenetic trees but was twice as distant from SIVcpzGAB1 and HIV-1 strains as they were from each other. This resulted in more support for a third unknown source being the true SIVcpz reservoir. [12]

Hahn was able to prove the original theory through analyzation of the SIVcpz phylogeny in relation to the subspecies origin of the infected chimpanzee host. [13] Her studies showed that the chimpanzees that had viruses similar to HIV-1 and to one another belonged to the same group; P.t. troglodytes. On the other hand, Noah, the chimpanzee with the virus that was extremely distant, was a P.t. schweinfurthii. [13] This proved that the origin of a subspecies' chimpanzee host was what was responsible for two different phylogenetic lineages of SIVcpz strains. Hahn's careful phylogenetic analysis also supported that the source of HIV-1 was the chimpanzees that were members of P.t. troglodytes. [13]

Honors and awards

Works

Related Research Articles

<span class="mw-page-title-main">HIV</span> Human retrovirus, cause of AIDS

The human immunodeficiency viruses (HIV) are two species of Lentivirus that infect humans. Over time, they cause acquired immunodeficiency syndrome (AIDS), a condition in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype.

Various fringe theories have arisen to speculate about purported alternative origins for the human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS), with claims ranging from it being due to accidental exposure to supposedly purposeful acts. Several inquiries and investigations have been carried out as a result, and each of these theories has consequently been determined to be based on unfounded and/or false information. HIV has been shown to have evolved from or be closely related to the simian immunodeficiency virus (SIV) in West Central Africa sometime in the early 20th century. HIV was discovered in the 1980s by the French scientist Luc Montagnier. Before the 1980s, HIV was an unknown deadly disease.

<i>Simian immunodeficiency virus</i> Species of retrovirus

Simian immunodeficiency virus (SIV) is a species of retrovirus that cause persistent infections in at least 45 species of non-human primates. Based on analysis of strains found in four species of monkeys from Bioko Island, which was isolated from the mainland by rising sea levels about 11,000 years ago, it has been concluded that SIV has been present in monkeys and apes for at least 32,000 years, and probably much longer.

The oral polio vaccine (OPV) AIDS hypothesis is a now-discredited hypothesis that the AIDS pandemic originated from live polio vaccines prepared in chimpanzee tissue cultures, accidentally contaminated with simian immunodeficiency virus and then administered to up to one million Africans between 1957 and 1960 in experimental mass vaccination campaigns.

<span class="mw-page-title-main">CCR5</span> Immune system protein

C-C chemokine receptor type 5, also known as CCR5 or CD195, is a protein on the surface of white blood cells that is involved in the immune system as it acts as a receptor for chemokines.

<span class="mw-page-title-main">History of HIV/AIDS</span> Epidemiological history

AIDS is caused by a human immunodeficiency virus (HIV), which originated in non-human primates in Central and West Africa. While various sub-groups of the virus acquired human infectivity at different times, the present pandemic had its origins in the emergence of one specific strain – HIV-1 subgroup M – in Léopoldville in the Belgian Congo in the 1920s.

<span class="mw-page-title-main">HIV/AIDS</span> Spectrum of conditions caused by HIV infection

Human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV), a retrovirus. Following initial infection an individual may not notice any symptoms, or may experience a brief period of influenza-like illness. Typically, this is followed by a prolonged incubation period with no symptoms. If the infection progresses, it interferes more with the immune system, increasing the risk of developing common infections such as tuberculosis, as well as other opportunistic infections, and tumors which are rare in people who have normal immune function. These late symptoms of infection are referred to as acquired immunodeficiency syndrome (AIDS). This stage is often also associated with unintended weight loss.

HIV/AIDS was recognised as a novel illness in the early 1980s. An AIDS case is classified as "early" if the death occurred before 5 June 1981, when the AIDS epidemic was formally recognized by medical professionals in the United States.

<span class="mw-page-title-main">CXCR6</span>

C-X-C chemokine receptor type 6 is a protein that in humans is encoded by the CXCR6 gene. CXCR6 has also recently been designated CD186.

<span class="mw-page-title-main">GANC</span> Protein-coding gene in the species Homo sapiens

Neutral alpha-glucosidase C is an enzyme that in humans is encoded by the GANC gene.

<span class="mw-page-title-main">Subtypes of HIV</span> Variants of the human immunodeficiency virus

The subtypes of HIV include two major types, HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV-1 is related to viruses found in chimpanzees and gorillas living in western Africa, while HIV-2 viruses are related to viruses found in the sooty mangabey, a vulnerable West African primate. HIV-1 viruses can be further divided into groups M, N, O and P. The HIV-1 group M viruses predominate and are responsible for the AIDS pandemic. Group M can be further subdivided into subtypes based on genetic sequence data. Some of the subtypes are known to be more virulent or are resistant to different medications. Likewise, HIV-2 viruses are thought to be less virulent and transmissible than HIV-1 M group viruses, although HIV-2 is also known to cause AIDS. One of the obstacles to treatment of the human immunodeficiency virus (HIV) is its high genetic variability.

Moloundou is an arrondissement (district) in the Boumba-et-Ngoko Division of southeastern Cameroon's East Province. Mouloundou is close to Boumba Bek and Nki National Parks on the Dja River. It has a mayor and several decentralised administrative services. Moloundou sits on the Ngoko River, directly across from Congo-Brazzaville.

<span class="mw-page-title-main">Françoise Barré-Sinoussi</span> French virologist and Nobel laureate (born 1947)

Françoise Barré-Sinoussi is a French virologist and Director of the Regulation of Retroviral Infections Division and Professor at the Institut Pasteur in Paris, France. Born in Paris, France, Barré-Sinoussi performed some of the fundamental work in the identification of the human immunodeficiency virus (HIV) as the cause of AIDS. In 2008, Barré-Sinoussi was awarded the Nobel Prize in Physiology or Medicine, together with her former mentor, Luc Montagnier, for their discovery of HIV. She mandatorily retired from active research on August 31, 2015 and fully retired by some time in 2017.

<span class="mw-page-title-main">Janice E. Clements</span> American biologist, academic and medical researcher

Janice Ellen Clements is vice dean for faculty at the Johns Hopkins School of Medicine and the Mary Wallace Stanton Professor of Faculty Affairs. She is a professor in the departments of Molecular and Comparative Pathobiology, Neurology, and Pathology, and has a joint appointment in molecular biology and genetics. Her molecular biology and virology research examines lentiviruses and how they cause neurological diseases.

Alexander F. Voevodin M.D., Ph.D., D.Sc., FRCPath is Russian-born biomedical scientist and educator. He is considered one of the leading early pioneers of HIV/AIDS research.

<span class="mw-page-title-main">Host switch</span> Evolutionary change of the host specificity of a parasite or pathogen

In parasitology and epidemiology, a host switch is an evolutionary change of the host specificity of a parasite or pathogen. For example, the human immunodeficiency virus used to infect and circulate in non-human primates in West-central Africa, but switched to humans in the early 20th century.

Anne Elizabeth Pusey is director of the Jane Goodall Institute Research Center and a professor of evolutionary anthropology at Duke University. Since the early 1990s, Pusey has been archiving the data collected from the Gombe chimpanzee project. The collection housed at Duke University consists of a computerized database that Pusey oversees. In addition to archiving Jane Goodall’s research from Gombe, she is involved in field study and advising students at Gombe. She was elected a member of the National Academy of Sciences in 2022.

<span class="mw-page-title-main">Bette Korber</span> American computational biologist

Bette Korber is an American computational biologist focusing on the molecular biology and population genetics of the HIV virus that causes infection and eventually AIDS. She has contributed heavily to efforts to obtain an effective HIV vaccine. She created a database at Los Alamos National Laboratory that has enabled her to design novel mosaic HIV vaccines, one of which is currently in human testing in Africa. The database contains thousands of HIV genome sequences and related data.

Theodora Hatziioannou is a Greek-American virologist. She known for her work discovering restriction factors that counteract HIV-AIDS and other primate lentiviruses, thus restricting them to specific species, and making it hard to study HIV-1 in animals. Her findings allowed her to develop the first HIV-1-based virus which is capable of recapitulating AIDS-like symptoms in a non-hominid. She is a Research Associate Professor in the Laboratory of Retrovirology at The Rockefeller University in New York. She is a co-author of a textbook on virology, Principles of Virology.

Janet K. Yamamoto is an American immunologist. Yanamoto is a professor of veterinary medicine at the University of Florida where she studies the spread of HIV/AIDS. In 1988, she co-developed a vaccine for the feline version of HIV with Niels C. Pederson and was subsequently elected to the National Academy of Inventors.

References

  1. 1 2 3 4 5 "Beatrice Hahn, MD". Center for HIV/AIDS Vaccine Immunology. Archived from the original on 2014-10-13. Retrieved 2016-04-02.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Viegas, Jennifer (2013-04-23). "Profile of Beatrice H. Hahn". Proceedings of the National Academy of Sciences. 110 (17): 6613–6615. Bibcode:2013PNAS..110.6613V. doi: 10.1073/pnas.1305711110 . ISSN   0027-8424. PMC   3637689 . PMID   23589843.
  3. 1 2 3 University of Alabama at Birmingham (May 26, 2006). "Researchers Confirm HIV-1 Originated In Wild Chimpanzees". Science Daily. Retrieved 19 October 2018.
  4. 1 2 3 4 5 Kreeger, Karen (April 21, 2016). "Beatrice H. Hahn, MD, Virologist from Penn's Perelman School of Medicine Elected to American Academy of Arts and Sciences". Penn Medicine. Retrieved 19 October 2018.
  5. 1 2 3 "Beatrice Hahn and George Shaw, Pioneers in HIV Research, to Join Penn Medicine". Penn Medicine. September 23, 2010. Retrieved 19 October 2018.
  6. 1 2 Svitil, Kathy (1 November 2002). "The 50 Most Important Women in Science". Discover. Retrieved 21 December 2014.
  7. 1 2 3 "Microbiology, Immunology, and Cancer Biology Seminar Series: Winford P. Larson Lectureship". University of Minnesota. Archived from the original on 20 October 2018. Retrieved 19 October 2018.
  8. ↑ Viegas, Jennifer (2013-04-23). "Profile of Beatrice H. Hahn". Proceedings of the National Academy of Sciences. 110 (17): 6613–6615. Bibcode:2013PNAS..110.6613V. doi: 10.1073/pnas.1305711110 . ISSN   0027-8424. PMC   3637689 . PMID   23589843.
  9. ↑ "Research Teams". CHAVI-ID. Retrieved 29 January 2020.
  10. ↑ "Beatrice H. Hahn, MD, Virologist from Penn's Perelman School of Medicine Elected to American Academy of Arts and Sciences". Penn Medicine News. Penn Medicine. Retrieved 29 January 2020.
  11. 1 2 "Beatrice H. Hahn, M.D." Perelman School of Medicine. University of Pennsylvania. Retrieved 2016-04-02.
  12. 1 2 3 4 5 6 7 8 Sharp, Paul; Hahn, Beatrice (27 August 2010). "The evolution of HIV-1 and the origin of AIDS". Philosophical Transactions of the Royal Society B: Biological Sciences. 365 (1552): 2487–2494. doi:10.1098/rstb.2010.0031. PMC   2935100 . PMID   20643738.
  13. 1 2 3 Sharp, Paul; Bailes, E; Chaudhuri, R; Rodenburg, CM; Santiago, MO; Hahn, BH (29 June 2001). "The origins of acquired immune deficiency syndrome viruses: where and when?". Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 356 (1410): 867–76. doi:10.1098/rstb.2001.0863. PMC   1088480 . PMID   11405934.
  14. ↑ "Past Honorees BBJ's Top Birmingham Women, 1989-2000". Birmingham Business Journal. Retrieved 19 October 2018.
  15. ↑ "Dr. Beatrice H. Hahn". Who's Who in Health Care: Creel-Hall. Oct 13, 2002. Retrieved 19 October 2018.
  16. ↑ "Eighth Annual David Derse Memorial Lecture and Award". National Cancer Institute Center for Cancer Research. Retrieved 1 September 2020.
  17. ↑ Baillie, Katherine Unger (May 1, 2012). "Three Penn Faculty Elected to the National Academy of Sciences". Penn Today. Retrieved 19 October 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.